UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Visualizing the elimination of sharkskin through fluoropolymer additives: Coating and polymer–polymer slippage

Journal of rheology (New York : 1978), 2001-03, Vol.45 (2), p.565-581

2001

Volltextzugriff (PDF)

A photoluminescence study of poly(phenylene vinylene) derivatives: The effect of intrinsic persistence length

The Journal of chemical physics, 1994-07, Vol.101 (2), p.1673-1678

1994

Volltextzugriff (PDF)

Solution characterization of surfactant solubilized polyaniline

Synthetic metals, 1995-09, Vol.74 (1), p.81-88

1995

Volltextzugriff (PDF)

Characterization of poly(3-octylthiophene). I: Molecular characterization in dilute solution

Polymer engineering and science, 1995-05, Vol.35 (10), p.860-867

1995

Volltextzugriff (PDF)

The effect of molecular weight and crystallinity on the conductivity of a conducting polymer

Polymer (Guilford), 1993, Vol.34 (15), p.3155-3159

1993

Volltextzugriff (PDF)

The Effect of Intrinsic Rigidity on the Optical Properties of PPV Derivatives

Molecular crystals and liquid crystals science and technology. Section A, Molecular crystals and liquid crystals, 1994-11, Vol.256 (1), p.507-512

1994

Volltextzugriff (PDF)

ChemInform Abstract: Solution Characterization of Surfactant Solubilized Polyaniline

ChemInform, 1996-02, Vol.27 (6), p.no-no

1996

Volltextzugriff (PDF)

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331

Annals of oncology, 2021-05, Vol.32 (5), p.631-641

2021

Volltextzugriff (PDF)

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1070-1077

2017

Volltextzugriff (PDF)

Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

Annals of oncology, 2021-12, Vol.32 (12), p.1597-1607

2021

Volltextzugriff (PDF)

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Annals of oncology, 2018-04, Vol.29 (4), p.959-965

2018

Volltextzugriff (PDF)

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

The lancet oncology, 2020-05, Vol.21 (5), p.655-663

2020

Volltextzugriff (PDF)

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Journal of clinical oncology, 2019-02, Vol.37 (4), p.278-285

2019

Volltextzugriff (PDF)

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

The New England journal of medicine, 2012-06, Vol.366 (26), p.2443-2454

2012

Volltextzugriff (PDF)

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

Diabetes (New York, N.Y.), 2018-08, Vol.67 (8), p.1471-1480

2018

Volltextzugriff (PDF)

Efficacy and Safety of Epoetin Alfa in Critically Ill Patients

The New England journal of medicine, 2007-09, Vol.357 (10), p.965-976

2007

Volltextzugriff (PDF)

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-10, Vol.373 (17), p.1627-1639

2015

Volltextzugriff (PDF)

Influence of WC-Co hard metal microstructure on defect density, initiation and propagation kinetics of fatigue cracks starting at intrinsic and artificial defects under a negative stress ratio

Acta materialia, 2020-04, Vol.188, p.30-39

2020

Volltextzugriff (PDF)

1330 Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.S114-S114

2016

Volltextzugriff (PDF)

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature medicine, 2023-09, Vol.29 (9), p.2334-2346

2023

Volltextzugriff (PDF)

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)

Clinical lung cancer, 2021-07, Vol.22 (4), p.313-323.e1

2021

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(30)
Humans
(28)
Female
(18)
Male
(17)
Oncology
(16)
Middle Aged
(14)
Aged
(12)
Biological And Medical Sciences
(11)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Adult
(10)
Immunotherapy
(8)
Lung Neoplasms - Drug Therapy
(8)
General & Internal Medicine
(7)
Medical Sciences
(7)
Aged, 80 And Over
(6)
Antineoplastic Agents - Therapeutic Use
(6)
Carcinoma, Non-Small-Cell Lung - Genetics
(6)
Lung Neoplasms - Pathology
(6)
Lung Cancer
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Visualizing the elimination of sharkskin through fluoropolymer additives: Coating and polymer–polymer slippage

A photoluminescence study of poly(phenylene vinylene) derivatives: The effect of intrinsic persistence length

Solution characterization of surfactant solubilized polyaniline

Characterization of poly(3-octylthiophene). I: Molecular characterization in dilute solution

The effect of molecular weight and crystallinity on the conductivity of a conducting polymer

The Effect of Intrinsic Rigidity on the Optical Properties of PPV Derivatives

ChemInform Abstract: Solution Characterization of Surfactant Solubilized Polyaniline

Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

Efficacy and Safety of Epoetin Alfa in Critically Ill Patients

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)

Influence of WC-Co hard metal microstructure on defect density, initiation and propagation kinetics of fatigue cracks starting at intrinsic and artificial defects under a negative stress ratio

1330 Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)

Suchergebnisse filtern